Carbamic acid,N-methyl-N-nitroso-, ethyl ester cas no:615-53-2

NameCarbamic acid,N-methyl-N-nitroso-, ethyl ester
CAS615-53-2
SynonymsCarbamicacid, methylnitroso-, ethyl ester (6CI,8CI,9CI); EthylN-methylnitrosocarbamate; Methylnitrosourethane; N-Methyl-N-nitrosourethane;N-Nitroso-N-methylurethane; NMU; NSC 2860; Nitrosomethylurethane
EINECS(EC#)210-432-3
Molecular FormulaC4H8 N2 O3
Molecular Weight132.14

refractive index1.462
storage tempRefrigerator

Hazardclass1.1A

Safety

Confirmed carcinogen with experimental carcinogenic, tumorigenic, and teratogenic data. Poison by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Moderately toxic by inhalation. Experimental reproductive effects. Mutation data reported. Has been implicated as a transplacental brain carcinogen. Combustible when exposed to heat, sparks, open flame, and powerful oxidizers. Explodes when heated. A storage hazard. When heated to decomposition it emits toxic fumes of NO_x. See also NITROSAMINES and CARBAMATES.

Risk Statements 5-36/37/38-40
R5 : Heating may cause an explosion. 
R36/37/38: Irritating to eyes, respiratory system and skin. 
R40: Limited evidence of a carcinogenic effect.
Safety Statements 23-35-45-53
S23: Do not breathe vapour. 
S35: This material and its container must be disposed of in a safe way. 
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) 
S53: Avoid exposure - obtain special instructions before use.
RIDADR: 2810
RTECS: FC6300000
HazardClass: 1.1A
PackingGroup: I

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
hamster	LDLo	subcutaneous	21mg/kg (21mg/kg)		American Journal of Pathology. Vol. 50, Pg. 639, 1967.
mammal (species unspecified)	LD50	intravenous	4mg/kg (4mg/kg)		Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975.
mammal (species unspecified)	LD50	oral	240mg/kg (240mg/kg)		Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975.
mouse	LCLo	inhalation	600mg/m3/10M (600mg/m3)		National Defense Research Committee, Office of Scientific Research and Development, Progress Report.Vol. NDCrc-132, Pg. MAR1942,
mouse	LD50	intraperitoneal	37mg/kg (37mg/kg)		Cancer Research. Vol. 30, Pg. 11, 1970.
mouse	LDLo	subcutaneous	7mg/kg (7mg/kg)		British Journal of Cancer. Vol. 23, Pg. 167, 1969.
rat	LD50	intravenous	4mg/kg (4mg/kg)		Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967.
rat	LD50	oral	180mg/kg (180mg/kg)		Naturwissenschaften. Vol. 48, Pg. 165, 1961.
rat	LDLo	intraperitoneal	50mg/kg (50mg/kg)		British Journal of Cancer. Vol. 22, Pg. 316, 1968.
rat	LDLo	subcutaneous	125mg/kg (125mg/kg)		British Journal of Cancer. Vol. 16, Pg. 92, 1962.